USAMRIID

Messenger RNA Technology Could Be Used to Develop Infectious Disease Therapeutics

Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)–the technology recently used in COVID-19 vaccines and others–could also be used to develop treatments for infectious diseases.

read full story »

Soldier finds success, citizenship in US Army

Austin, Texas – Sgt. Ibrahim Toure had planned and waited for years to make it to the United States, a place he thought of as offering greater freedom and possibilities.

read full story »

Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process

Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.

read full story »

Antibody Shows Promise for Developing Hantavirus Treatment

An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine.

read full story »

USAMRIID Scientist Wins AMSUS Research and Development Award

Xiankun (Kevin) Zeng, Ph.D., a molecular biologist and principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), is the recipient of the 2021-2022 Research and Development Award presented by AMSUS, the Society of Federal Health Professionals.

read full story »

Study Reveals Ebola Virus Can Hide in Brain, Persist Even After Treatment

In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease–even long after treatment with monoclonal antibodies.

read full story »

Scientists Develop First Lethal Hamster Model for COVID-19

Army scientists, in collaboration with Utah State University, have developed a lethal hamster model for SARS-CoV-2, the virus that causes COVID-19.

read full story »

Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection

Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease.

read full story »

Bootstrap Slider

Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.